Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

Jean-François Gagnon1, Mélanie Vendette, Ronald B Postuma

  • 1Centre d'étude du Sommeil et des Rythmes Biologiques, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada. jean-francois.gagnon.5@umontreal.ca

Annals of Neurology
|August 12, 2009
PubMed
Abstract

Insights

Mild cognitive impairment (MCI) is common in idiopathic rapid eye movement sleep behavior disorder (RBD) and Parkinson's disease (PD) with RBD. RBD is a significant risk factor for cognitive decline in these conditions.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Cognitive Neuroscience

Background:

  • Idiopathic rapid eye movement sleep behavior disorder (RBD) and Parkinson's disease (PD) are neurodegenerative conditions.
  • Mild cognitive impairment (MCI) is a potential precursor to dementia.
  • The relationship between RBD and MCI, particularly in the context of PD, requires further investigation.

Purpose of the Study:

  • To determine the prevalence and subtypes of MCI in individuals with idiopathic RBD and PD with RBD.
  • To compare MCI rates between idiopathic RBD, PD with RBD, PD without RBD, and healthy controls.
  • To identify potential cognitive differences associated with RBD in PD.

Main Methods:

  • A comprehensive neuropsychological evaluation was performed on 112 participants.
  • Participants included 32 idiopathic RBD patients, 22 PD patients with polysomnography-confirmed RBD, 18 PD patients without RBD, and 40 healthy controls.
  • MCI was diagnosed using standard criteria, and group comparisons were conducted.

Main Results:

  • MCI was diagnosed in 50% of idiopathic RBD patients and 73% of PD patients with RBD.
  • MCI rates were significantly higher in idiopathic RBD and PD with RBD groups compared to PD without RBD and controls (11% and 8%, respectively).
  • PD patients with RBD showed poorer performance in visuoconstructional and visuoperceptual tasks compared to idiopathic RBD patients.

Conclusions:

  • Rapid eye movement sleep behavior disorder (RBD) is a significant risk factor for mild cognitive impairment (MCI), both in its idiopathic form and when associated with Parkinson's disease (PD).
  • RBD appears to be a key determinant of cognitive impairment in PD, with specific deficits in visuoconstructional and visuoperceptual abilities.

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...